- Advertisement -
- Advertisement -

Related

Swedish Hedge Funds Among Institutional Investors in Immunicum Directed Share Issue

Latest Report

- Advertisement -

Stockholm (HedgeNordic) – Immunicum, a Swedish company said to be creating the blue print for the world’s first personalized, off-the-shelf affordable cancer treatment, has decided to implement a directed issue of approximately SEK 178 million and a rights issue of approximately SEK 173 million, according to a press release.

The money to be raised is aimed at continuing to finance the clinical development of the company´s immunotherapeutical drug ilixadencel.

Several institutions are among the investors subscribing to the directed issue including three Swedish hedge fund companies; Gladiator, Nordic Cross, and Adrigo. Other institutions include AP2, AP4, and Alfred Berg.

Photo by Louis Reed on Unsplash.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.

Latest Articles

Mapping the Finnish Hedge Fund Landscape

Beyond operating as a media platform, HedgeNordic maintains an extensive database of Nordic hedge funds and related data. Although the data is not without...

Quirky Questions for Serge Houles (Tidan Capital)

Not every conversation in the hedge fund world needs to revolve around alpha, Sharpe ratios, or fund flows. In the ongoing Quirky Questions series,...

Quirky Questions for Mette Østerbye Vejen (Caba Capital)

Not every conversation in the hedge fund world needs to revolve around alpha, Sharpe ratios, or fund flows. In the ongoing Quirky Questions series,...

Solid First-Half Finish for Nordic Hedge Funds

Nordic hedge funds wrapped up the first half of the year on a solid note, delivering an average gain of 1.4 percent in June....

Brevan Howard Winds Down Volatility Fund Managed by Ville Helske

Brevan Howard Asset Management is winding down a volatility-focused hedge fund run by high-profile Finnish portfolio manager Ville Helske. Helske, formerly Head of Allocation...

Ymer to Launch Fourth CLO Fund with Proven Strategy and Structure

Building on the track record of three previous credit funds, Swedish alternative credit specialist Ymer SC AB is preparing to roll out its fourth...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -
HedgeNordic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.